✦ LIBER ✦

Impact of depressive symptoms on the treatment of generalized social anxiety disorder

✍ Scribed by Deborah Roth Ledley; Jonathan D. Huppert; Edna B. Foa; Jonathan R.T. Davidson; Francis J. Keefe; Nicholas L.S. Potts

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 124 KB
Volume: 22
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.20121

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Examination of the decline in symptoms o

Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy

✍ Bunmi O. Olatunji; Greg Feldman; Jasper A. J. Smits; Kelly M. Christian; Alyson 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Citalopram treatment of social anxiety d

Citalopram treatment of social anxiety disorder with comorbid major depression

✍ Franklin R. Schneier; Carlos Blanco; Raphael Campeas; Roberto Lewis-Fernandez; S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Social anxiety and insomnia: the mediati

Social anxiety and insomnia: the mediating role of depressive symptoms

✍ Julia D. Buckner; Rebecca A. Bernert; Kiara R. Cromer; Thomas E. Joiner; Norman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Anxiety is commonly associated with insomnia. Given that social anxiety disorder is one of the most prevalent anxiety disorders, socially anxious individuals may be particularly vulnerable to insomnia. However, there is currently very little empirical work on this relationship. This study used bivar

The efficacy of nefazodone augmentation

The efficacy of nefazodone augmentation for treatment-resistant depression with anxiety symptoms or anxiety disorder

✍ Fletcher B. Taylor; Maureen R. Prather 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Depression that fails to respond to multiple antidepressant trials, particularly when accompanied by anxiety, constitutes a difficult treatment challenge. Those with anxious depression may be less likely to respond to treatment than their cohorts without anxiety. Anxiety symptoms also predict a high

Sudden gains in the treatment of general

Sudden gains in the treatment of generalized anxiety disorder

✍ Julie Present; Paul Crits-Christoph; Mary Beth Connolly Gibbons; Bridget Hearon; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

## Abstract The objective of this study was to investigate the prevalence and timing of sudden gains over the course of brief, psychodynamically oriented treatment for generalized anxiety disorder (GAD). Data were used from two studies of brief (i.e., 16‐session) supportive‐expressive psychotherapy

Efficacy of ondansetron in the treatment

Efficacy of ondansetron in the treatment of generalized anxiety disorder

✍ A. M. Freeman III; J. R. Westphal; G. T. Norris; B. A. Roggero; P. B. Webb; K. L 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

Ondansetron is a highly selective antagonist at the 5-HT 3 subtype of serotonin (5-HT) receptors . The 5-HT 3 receptors are the only receptors whose effects are mediated through the ion channels rather than the G-protein series . Ondansetron has no appreciable affinity for other 5-HT receptor subtyp